Benitec Biopharma (BNTC)

Benitec Biopharma Proprietary Limited • Benitec Australia Proprietary Limited • Benitec Limited • Benitec, Inc. • RNAi Therapeutics, Inc. • Tacere Therapeutics, Inc. • Benitec, LLC • Benitec IP Holdings, Inc. ...

BNTC stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

8-K

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

14 Feb 25

Departure of Directors or Certain Officers

31 Dec 24

8-K

Departure of Directors or Certain Officers

13 Dec 24

8-K

Material Modifications to Rights of Security Holders

10 Dec 24

8-K

Submission of Matters to a Vote of Security Holders

6 Dec 24

8-K

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

14 Nov 24

DEFA14A

Additional proxy soliciting materials

Departure of Directors or Certain Officers

14 Nov 24

Transcripts

BNTC

Earnings call transcript

2018 Q3

1 Jun 18

Latest ownership filings

View all

SC 13G/A

JANUS HENDERSON GROUP PLC

14 Feb 25

SC 13G/A

HBM Healthcare Investments (Cayman) Ltd.

13 Feb 25

SC 13G/A

FRANKLIN RESOURCES INC

Financial summary

Financial statements Chart BNTC financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	78.35 mm	78.35 mm	78.35 mm	78.35 mm	78.35 mm	78.35 mm
Cash burn (monthly)	(no burn)	(no burn)	2.87 mm	2.01 mm	2.57 mm	1.81 mm
Cash used (since last report)	n/a	n/a	5.92 mm	4.14 mm	5.30 mm	3.74 mm
Cash remaining	n/a	n/a	72.42 mm	74.20 mm	73.05 mm	74.61 mm
Runway (months of cash)	n/a	n/a	25.2	37.0	28.4	41.2

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

BNTC institutional ownership history Ownership history

97.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	36	15	+140.0%
Opened positions	21	1	+2000.0%
Closed positions	0	10	EXIT
Increased positions	6	5	+20.0%
Reduced positions	2	2	–

13F shares	Current	Prev Q	Change
Total value	240.18 bn	12.54 bn	+1815.1%
Total shares	22.82 mm	13.92 mm	+63.9%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Suvretta Capital Management	8.96 mm	$113.16 bn	+1.5%
BEN Franklin Resources	2.94 mm	$37.12 bn	+269.0%
JHG Janus Henderson	2.62 mm	$33.27 bn	NEW
Adage Capital Partners GP, L.L.C.	1.97 mm	$24.91 bn	NEW
CVI Investments	1.47 mm	$0.00	0.0%
HBM Healthcare Investments	1.04 mm	$11.37 mm	0.0%
Nantahala Capital Management	838.10 k	$10.59 bn	NEW
Oliveira Steven Michael	746.32 k	$5.01 mm	0.0%
Lincoln Park Capital Fund	423.53 k	$0.00	0.0%
Vanguard	300.02 k	$3.79 bn	+40.8%

Largest transactions	Shares	Bought/sold	Change
JHG Janus Henderson	2.62 mm	+2.62 mm	NEW
BEN Franklin Resources	2.94 mm	+2.14 mm	+269.0%
Adage Capital Partners GP, L.L.C.	1.97 mm	+1.97 mm	NEW
Nantahala Capital Management	838.10 k	+838.10 k	NEW
Schonfeld Strategic Advisors	260.42 k	+260.42 k	NEW
Infinitum Asset Management	210.00 k	+210.00 k	NEW
BlackRock	173.75 k	+145.51 k	+515.3%
Suvretta Capital Management	8.96 mm	+130.96 k	+1.5%
Geode Capital Management	197.10 k	+113.11 k	+134.7%
AWM Investment	102.03 k	+102.03 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BNTC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Dec 24	Suvretta Capital Management	Common stock, par value $0.0001 per share	Buy	Acquire P	Yes	No	11.25	2,288	25.74 k	960,554
24 Dec 24	Suvretta Capital Management	Common stock, par value $0.0001 per share	Buy	Acquire P	Yes	No	11.25	17,730	199.46 k	7,999,455
23 Dec 24	Suvretta Capital Management	Common stock, par value $0.0001 per share	Buy	Acquire P	Yes	No	10.98	3,142	34.50 k	958,266
23 Dec 24	Suvretta Capital Management	Common stock, par value $0.0001 per share	Buy	Acquire P	Yes	No	10.98	24,360	267.47 k	7,981,725
9 Dec 24	Megan Boston	Options Common Stock	Grant	Acquire A	No	No	12.18	720,000	8.77 mm	720,000
9 Dec 24	Jerel A. Banks	Options Common Stock	Grant	Acquire A	No	No	12.18	2,310,000	28.14 mm	2,310,000
9 Dec 24	Buchi J Kevin	Options Common Stock	Grant	Acquire A	No	No	12.18	35,000	426.30 k	35,000